Antiviral Combination Clinically Better Than Standard Therapy in Severe but Not in Non-Severe COVID-19

Overview of attention for article published in Clinical Pharmacology : Advances and Applications, September 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)

Mentioned by

policy: 1 policy source

twitter: 1 X user

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 29 Mendeley

Summary Policy documents X Dimensions citations

So far, Dimensions has found 4 publications that cite this research output.

4

The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.

Efficacy and safety of casirivimab-imdevimab combination on COVID-19 patients: A systematic review and meta-analysis randomized controlled trial

Article in Heliyon (November 2023)

Profiles of Independent-Comorbidity Groups in Senior COVID-19 Patients Reveal Low Fatality Associated with Standard Care and Low-Dose Hydroxychloroquine over Antivirals [Letter]

Article in Journal of Multidisciplinary Healthcare (May 2023)

COVID-19-related liver injury: Focus on genetic and drug-induced perspectives

Article in World Journal of Virology (January 2023)